Thomas Reiser/LinkedIn
Dec 11, 2025, 23:36
Register for the ISTH Andexanet Research Recap
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), posted on LinkedIn:
”How do researchers evaluate the effects of andexanet in healthy volunteers and patients with acute major bleeding on enoxaparin?
Register for the upcoming International Society on Thrombosis and Haemostasis (ISTH) RPTH Journal Research Recap on
December 18 (17:00 UTC) with author Thijs van Haaps and Moderator Lara Roberts.”
Stay updated with Hemostasis Today.
-
Jul 5, 2026, 22:51Shahzaib Akram: What Are We Actually Seeing When a Sickling Test Goes Positive?
-
Jul 5, 2026, 21:474 Tips for Exercising with A Bleeding Disorder – Haemophilia Foundation Australia
-
Jul 5, 2026, 21:06Heghine Khachatryan: Toward Personalized Management of Glanzmann Thrombasthenia
-
Jul 5, 2026, 21:06Priyanka Kumari: IV Fluids and Isotonic Solution
-
Jul 5, 2026, 21:05Ahmed Rizq: Would You Thrombolyse a Stable Patient?
-
Jul 5, 2026, 21:03Emmanuel Obeng Ofori: Diagnosing Anaemia – Why Treating the Root Cause Matters More Than Simply Raising the Haemoglobin
-
Jul 5, 2026, 21:02Mohit Koladia: The Pharmacist’s Role in Stroke Prevention for Atrial Fibrillation
-
Jul 5, 2026, 20:22J. Meireles-Brandao: Exploring the Approach to Thrombophillias
-
Jul 5, 2026, 20:13Kavya Keerthana: The Platelet Count Everyone Calls ‘Reactive’ Until It Isn’t